- Home
- CTMX vs KTF Comparison
CTMX vs KTF Comparison
Compare CTMX & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- KTF
- Stock Information
- Founded
- CTMX 2008
- KTF 1988
- Country
- CTMX United States
- KTF United States
- Employees
- CTMX N/A
- KTF N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- CTMX Health Care
- KTF Finance
- Exchange
- CTMX Nasdaq
- KTF Nasdaq
- Market Cap
- CTMX 349.6M
- KTF 337.7M
- IPO Year
- CTMX 2015
- KTF N/A
- Fundamental
- Price
- CTMX $1.93
- KTF $9.26
- Analyst Decision
- CTMX Strong Buy
- KTF
- Analyst Count
- CTMX 4
- KTF 0
- Target Price
- CTMX $5.13
- KTF N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- KTF 103.3K
- Earning Date
- CTMX 11-06-2025
- KTF 01-01-0001
- Dividend Yield
- CTMX N/A
- KTF 3.54%
- EPS Growth
- CTMX 263.20
- KTF N/A
- EPS
- CTMX 0.49
- KTF 0.39
- Revenue
- CTMX $141,100,000.00
- KTF N/A
- Revenue This Year
- CTMX N/A
- KTF N/A
- Revenue Next Year
- CTMX N/A
- KTF N/A
- P/E Ratio
- CTMX $3.98
- KTF $23.10
- Revenue Growth
- CTMX 18.01
- KTF N/A
- 52 Week Low
- CTMX $0.40
- KTF $7.40
- 52 Week High
- CTMX $3.10
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- CTMX 41.17
- KTF 76.95
- Support Level
- CTMX $1.90
- KTF $9.22
- Resistance Level
- CTMX $2.16
- KTF $9.33
- Average True Range (ATR)
- CTMX 0.13
- KTF 0.09
- MACD
- CTMX -0.01
- KTF 0.04
- Stochastic Oscillator
- CTMX 7.50
- KTF 89.39
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.